U.S. approves sale of 70,000 AI chips to UAE and Saudi Arabia, WSJ reports
Investing.com -- Meihua International Medical Technologies Co Ltd (NASDAQ:MHUA) stock plunged 19.2% in after-hours trading Wednesday following the company’s announcement of a 1-for-100 reverse stock split.
The China-based medical device manufacturer said the reverse split will be effective at the open of business on Monday, November 24, 2025, and will reduce its outstanding ordinary shares from approximately 56 million to about 0.56 million. The company stated that the move is intended to regain compliance with Nasdaq’s minimum bid price requirement of $1.00 per share.
Following the split, Meihua’s class A ordinary shares will have a new par value of $0.05 per share and will continue trading on Nasdaq under the symbol "MHUA" with a new CUSIP number. No fractional shares will be issued, with all fractional interests rounded up to the nearest whole number of Class A Ordinary Shares.
The company also plans to implement a dual-class share structure concurrent with the reverse split. Both the reverse split and dual-class structure were approved by shareholders on November 8, 2025.
VStock Transfer, LLC will serve as the exchange agent for the reverse split. Shareholders holding shares in book-entry form or brokerage accounts will not need to take any action, while those with certificates will receive instructions regarding the exchange process.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.